You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Wednesday announced a research and development agreement with Mayo Clinic to apply artificial intelligence (AI), machine learning (...
18 February 2026 - Clinical-stage biopharmaceutical company Palisade Bio Inc (Nasdaq:PALI) announced on Tuesday the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board.The company said that Dr. Verstockt is an internationally recog...
18 February 2026 - Pre-clinical stage immuno-oncology company Liminatus Pharma Inc (NASDAQ:LIMN) announced on Tuesday the pricing of its best-efforts public offering of 13,813,000 shares of its common stock (or pre-funded warrants in lieu thereof) an...
17 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd (NYSE:TEVA) (TASE:TEVA), on Tuesday reported positive long-term extension results fr...
17 February 2026 - First Ascent Biomedical, an oncology decision support platform, announced on Monday the official opening of a Functional Precision Medicine (FPM) laboratory in Miami, Florida.The Miami lab is now accepting patient samples through p...
17 February 2026 - Immunology company Nucleome Therapeutics announced on Monday the appointment of Dr Michelle Morrow as its chief scientific officer (CSO), effective 23 February 2026.Dr Morrow has two decades of experience in drug discovery and deve...
16 February 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) on Monday reported positive topline data from the Phase 3 LIBRETTO-432 trial evaluating Retevmo (selpercatinib) as adjuvant therapy in patients with stage II–IIIA RET fusion-...